Vishnu Chemicals
Vishnu Chemicals Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
2 of 3 strong
The short version
Revenue growth driven by both volume increases and value/realization improvements (Q1 FY27 saw ~25% YoY growth). Vishnu Chemicals reported over 20% year-on-year growth in both operating revenue and PAT in Q1 FY27, indicating strong growth momentum. - The company targets a 20% EBITDA margin over the long term. - Growth drivers include capacity additions in specialty chemicals (e.g., DMSO), backward integration in the barium business, scaling up of the strontium segment, and commencing South African operations expected in H2 FY27. - Shift towards higher value-added chromium derivatives is expected to improve margins. - Despite near-to-medium term headwinds from geopolitical tensions and increased logistics costs, the company remains optimistic about medium-term growth supported by diversified geography and strategic supply agreements. - Capex investments of approx.
From Vishnu Chemicals's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Revenue growth driven by both volume increases and value/realization improvements (Q1 FY27 saw ~25% YoY growth).
- Focus on growing specialty chemicals like DMSO with capex of over INR 200 crores underway.
- Expanding backward integration in barium business to improve raw material security and product quality.
- Scaling up production in strontium business aiming to increase capacity utilization from 50% to 65-75% by year-end.
- Strategic shift toward higher value-added chromium derivatives (like Chromic Acid, Chrome Oxide Green) to improve product mix.
- South Africa mine operations expected to start contributing in H2 FY27, improving competitiveness and gross margins.
- Domestic sales emphasis planned to offset higher logistics costs in near term.
2 more points from Vishnu Chemicals's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Vishnu Chemicals said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Total capex planned is close to INR360 crores.
- Over INR200 crores is dedicated to Dimethyl Sulfoxide (DMSO), an import replacement solvent for pharma and agro industries.
- Significant investment (~INR350 crores) to enhance Chrome Oxide Green production at Vizag plant, utilizing more Sodium Dichromate.
- Additional marginal capex planned for mine improvements.
- Past capex (~INR240-250 crores) focused on Chrome Oxide Green expansion and DMSO.
- Solar power capacity expansion: investing INR5-6 crores to increase solar from 5 MW to 20 MW, aiming for power cost reduction.
- Backward integration in barium business with capex close to INR40 crores.
2 more points from Vishnu Chemicals's call on capex
Pro opens every point from 15K+ earnings calls
Fundraising & Capital Structure
See what Vishnu Chemicals said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Vishnu Chemicals has secured a strategic, long-term binding supply agreement for Chrome Oxide Green with fixed volumes set for the next 10 years, providing visibility and stability compared to spot quarterly sales.
- The company is working on increasing volumes in the export market, as mentioned in recent communications.
- Production from the South Africa mine is expected to commence by the second half of FY27, which will contribute to future order fulfillment and margin improvements.
2 more points from Vishnu Chemicals's call on order book
Pro opens every point from 15K+ earnings calls
Vishnu Chemicals — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹411 Cr, net profit ₹34 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Vishnu Chemicals Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Thirumalai Chemicals Ltd (Q1 FY27)
Consolidated Revenue from Operations: INR 547 Cr (22% YoY increase from INR 450 Cr in Q1 FY26) . Key investor presentation takeaways from Thirumalai Chemicals L
- Neochem Bio Solutions Ltd (Q1 FY27)
Revenue from Operations in H2 FY26: ₹64.9 crore . Key investor presentation takeaways from Neochem Bio's Q1 FY27 investor presentation — and how it ranks agains
- Prasol Chemicals Ltd (Q1 FY27)
However, the company indicates strong demand with orders leading to capacity utilization rising from 12% to over 60% at the Mahad plant. Key concall takeaways…
- Fine Organic Industries Ltd (Q1 FY27)
Revenue from Operations (Consolidated) for Q1FY27: Rs 694.2 Cr, up 18.0% YoY from Rs 588.4 Cr in Q1FY26 (Page 34). Key concall takeaways from Fine Organic…
Arthneeti Pro · Annual
Vishnu Chemicals and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Vishnu Chemicals Q1 FY27 results?
Revenue growth driven by both volume increases and value/realization improvements (Q1 FY27 saw ~25% YoY growth). Vishnu Chemicals reported over 20% year-on-year growth in both operating revenue and PAT in Q1 FY27, indicating strong growth momentum. - The company targets a 20% EBITDA margin over the long term. - Growth drivers include capacity additions in specialty chemicals (e.g., DMSO), backward integration in the barium business, scaling up of the strontium segment, and commencing South African operations expected in H2 FY27. - Shift towards higher value-added chromium derivatives is expected to improve margins. - Despite near-to-medium term headwinds from geopolitical tensions and increased logistics costs, the company remains optimistic about medium-term growth supported by diversified geography and strategic supply agreements. - Capex investments of approx.
What is Vishnu Chemicals share price analysis?
Vishnu Chemicals currently shows a below-average growth signal. The stock trades at a P/E of 28.3 with a market cap of ₹4,236 Cr. Investors should review the full earnings analysis for detailed insights.
Is Vishnu Chemicals planning capital expenditure?
Total capex planned is close to INR360 crores.
Keep Vishnu Chemicals on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.